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Abstract
The lack of affordable techniques for gene transfer in birds has inhibited the advancement of molecular studies in avian
species. Here we demonstrate a new approach for introducing genes into chicken somatic tissues by administration of a
lentiviral vector, derived from the feline immunodeficiency virus (FIV), into the chorioallantoic membrane (CAM) of chick
embryos on embryonic day 11. The FIV-derived vectors carried yellow fluorescent protein (YFP) or recombinant alpha-
melanocyte-stimulating hormone (a-MSH) genes, driven by the cytomegalovirus (CMV) promoter. Transgene expression,
detected in chicks 2 days after hatch by quantitative real-time PCR, was mostly observed in the liver and spleen. Lower
expression levels were also detected in the brain, kidney, heart and breast muscle. Immunofluorescence and flow cytometry
analyses confirmed transgene expression in chick tissues at the protein level, demonstrating a transduction efficiency of
,0.46% of liver cells. Integration of the viral vector into the chicken genome was demonstrated using genomic repetitive
(CR1)-PCR amplification. Viability and stability of the transduced cells was confirmed using terminal deoxynucleotidyl
transferase (dUTP) nick end labeling (TUNEL) assay, immunostaining with anti-proliferating cell nuclear antigen (anti-PCNA),
and detection of transgene expression 51 days post transduction. Our approach led to only 9% drop in hatching efficiency
compared to non-injected embryos, and all of the hatched chicks expressed the transgenes. We suggest that the
transduction efficiency of FIV vectors combined with the accessibility of the CAM vasculature as a delivery route comprise a
new powerful and practical approach for gene delivery into somatic tissues of chickens. Most relevant is the efficient
transduction of the liver, which specializes in the production and secretion of proteins, thereby providing an optimal target
for prolonged study of secreted hormones and peptides.
Citation: Hen G, Yosefi S, Shinder D, Or A, Mygdal S, et al. (2012) Gene Transfer to Chicks Using Lentiviral Vectors Administered via the Embryonic Chorioallantoic
Membrane. PLoS ONE 7(5): e36531. doi:10.1371/journal.pone.0036531
Editor: Xiuhcun (Cindy) Tian, University of Connecticut, United States of America
Received August 17, 2011; Accepted April 3, 2012; Published May 11, 2012
Copyright:  2012 Hen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by grants from the Chief Scientist Ministry of Agriculture, Israel, The Hebrew University Lohenshtein Fund for Medical Research
and The Deutsche Forschungsgemeinschaft, grant number SFB 841. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: seladon@agri.huji.ac.il (DSD); einat@agri.huji.ac.il (MFE)
Introduction
For several decades now, great effort has been invested in
producing transgenic chickens [1–3]. Inherited biological and
anatomical obstacles to avian transgenesis, arising from the unique
anatomy of the avian reproductive system and a low rate of
genomic incorporation of foreign DNA, have prevented the
adaptation of protocols routinely used in mice. Therefore,
alternative approaches were developed for chicken transgenesis,
such as: (i) infection of primordial germ cells by viral injection into
the subgerminal cavity of the newly laid egg [3–5], or at a later
stage of development, upon primordial germ cell migration to the
gonads through the circulation on embryonic day 2.5 (E2.5) [6];
(ii) injection of in vitro-modified embryonic stem cells or primordial
germ cells, either employing non-viral vector systems, which allow
insertion of large DNA fragments [7–10], or by utilizing viral
vectors [11]. However, production of transgenic chickens using
these approaches is much less efficient and more complex than
transgenesis in other model animals, thereby preventing their
routine use for research purposes.
In contrast to the high complexity of the existing techniques for
stable transgenesis in adult birds, transient transgenesis in chick
embryos is widely used for developmental biology studies (for
review see [12]). However, these approaches are not compatible
with long term development and hatch.
Among the reported viruses used for transduction of chicken
cells, lentiviruses appear to be the most efficient [4,11]. Efficacy of
lentiviral vectors in several clinical trials has been recently
reported, such as use for gene-therapy studies in human cancer
patients [13]. Lentiviral vectors are considered the preferred
vector system for gene therapy due to their competence in
transducing a wide variety of cell types, their unique ability to
integrate into the genome of both dividing and non-dividing cells,
and their considerable resistance to gene silencing, resulting in
stable and long-term transgene expression [14–18].
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36531The chorioallantoic membrane (CAM) is the site of respiratory
gas exchange, calcium transport from the eggshell, acid-base
homeostasis in the embryo, and ion and H2O reabsorption from
the allantoic fluid. It consists of fused allantois and chorion
membranes and is rich in blood vessels. Its position proximal to
the shell membrane renders the CAM vasculature highly attractive
for a variety of research purposes, such as the delivery of cells or
chemicals to test tumor chemosensitivity [19], to study angiogenesis
and metastasis [20], to evaluate drug-delivery systems in preclinical
studies [21], and to assess the safety of cosmetic formulations [22].
In the current study, we present a new approach to gene
delivery into somatic tissues of chickens via administration of
lentiviral particles carrying either yellow fluorescent protein (YFP)
or recombinant alpha-melanocyte-stimulating hormone (a-MSH)
genes, into the CAM on embryonic day 11 (E11). Analysis of post-
hatch chicks showed that all of them expressed the transgene in
various tissues, with highest levels of expression in the liver and
spleen and lower levels in the brain, kidney, heart and breast
muscle. The combination of a simple injection into the embryonic
CAM and the use of an advanced feline immunodeficiency virus
(FIV)-derived vector system comprise a unique and powerful
method for gene delivery into somatic tissues of chicks.
Materials and Methods
Ethics Statement
All procedures were carried out in accordance with the National
Institutes of Health Guidelines on the Care and Use of Animals
and approved by the ‘‘Animal Experimentation Ethics Commit-
tee’’ of the ARO, Volcani Center (Protocol #356-0479-06).
Eggs, Incubation and Hatching Conditions
Fertile White Leghorn eggs were purchased from a local
husbandry (Wolf-Weisman, Sitriya, Israel). Incubation was
performed in a standard egg incubator, at 37.8uC and 56%
relative humidity (RH). Eggs were incubated with their narrow
end facing down, and rotated 90u once per hour. On E18, eggs
were transferred to the hatching compartment in the incubator
and incubation was continued at 37.8uC and 70% RH.
Hatchability was 90% for untreated eggs.
Plasmids
pLionII-YFP (http://www.stanford.edu/group/nolan/
retroviral_systems/felix_maps.html), which contains the gene
encoding YFP driven by the CMV promoter, was kindly donated
by Garry Nolan (Stanford University, Palo Alto, CA).
pLionII- a-MSH was constructed by digesting pLionII (Ad-
dgene, plasmid #1730) with EcoRV and inserting, downstream of
the CMV promoter, a blunted BamHI fragment containing the
sequence encoding human a-MSH from the plasmid pACTH1-17
(kindly donated by Dr. M.L. Hedley [23]). The a-MSH coding
sequences in this construct are composed of selected segments of
the human pro-opiomelanocortin (POMC) gene (signal peptide,
sorting peptide, partial junction peptide, a-MSH-encoding
sequence and a 12 base-pairs (bp) sequence encoding the a-
MSH amidation signal [23]). The full sequence of pLionII-a-MSH
(pLionII-pACTH1-17) was submitted to GenBank under accession
number: BankIt1497321 seq JQ086322.
Production of Viral Particles
Viral particles were produced as described previously [16].
Briefly, HEK293T cells were co-transfected with 8.4 mg of the
transfer vector (pLionII-YFP or pLionII- a-MSH), 14 mg packag-
ing vector pCPRDEnv (Addgene, plasmid #1732), and 5.6 mgo f
the envelope vector pCI-VSVG (Addgene, plasmid #1733) per
10 cm diameter plate, using 75 ml of Fugene reagent (Roche
Diagnostics, Pharma, Petach-Tikva, Israel). The VSV-G envelope
has a broaden viral tropism including avian cells [4]. FIV
transducing units (TU) were determined by titration of HEK293T
transduction using flow cytometry for FIV-YFP, as well as by real-
time quantitative (q) PCR (see below) for FIV-a-MSH, using
canonical packaging signal (y) primers F: 59- CGGACTC-
GAGCTCATAATCAAGT-39,R :5 9-
TGTCCCTCGGCGAATCTC-39. A known amount of pLionII-
a-MSH plasmid was used as a reference for calibration.
Cell Culture Conditions and Lentiviral Transduction
HEK293T cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% (v/v) fetal calf serum
(FBS), 2 mM glutamine, 100 mg/ml streptomycin and 100 U/ml
penicillin (Biological Industries, Bet-Haemek, Israel), at 37uCi na n
atmosphere containing 5% CO2. For transduction with the
lentiviral vectors, 1610
6 cells were seeded in a six-well plate
(Corning, Sigma-Aldrich, Rehovot, Israel) and transduced 1 day
later with FIV-YFP or FIV-a-MSH (2610
5 TU/well), estimated
as 0.1 TU/cell at the moment of transduction.
In vitro Transduction of Chicken Cells in Primary Cultures
with FIV-YFP
Liver, spleen, kidney, brain, heart and breast muscle (pectoralis)
were excised from E11 chicken embryos and dissociated with
2 mg/ml collagenase II, 0.15 mg/ml DNase I, 100 mg/ml
streptomycin and 100 U/ml penicillin in HBS (20 mM Hepes,
137 mM NaCl, 3 mM KCl, pH 7.4) for 20 min at 37uC, with
pipetting every 5 min. Dissociated cells were filtered through a
70 mm cell strainer (BD Falcon, Bactlab Diagnostics Ltd, Caesarea,
Israel) to enrich for a single-cell suspension, and treated with red
blood cell (RBC) lysing buffer (Sigma-Aldrich). Enrichment against
fibroblasts was performed by pre-plating the cells for 20 min in a
standard 24-well plate (Corning) before transferring the non-
attached cells to new plates coated with 0.01% (w/v) calf skin
collagen solution (Sigma-Aldrich). All cell types were cultured in
DMEM supplemented with 10% FBS. Liver culture medium was
also supplemented with ITS (Sigma-Aldrich), containing 5 mg/ml
recombinant human insulin, 5 mg/ml human transferrin and 5 ng/
ml sodium selenite. Twenty-four hours after plating, cells were
transduced by adding 300 ml of medium containing 2610
4 TU of
FIV-YFP, supplemented with polybrene (8 mg/ml; Sigma-Aldrich)
for 24 h. Two days after transduction, cells were washed with PBS
and fixed with 4% (w/v) paraformaldehyde (PFA) for 10 min or
analyzed by flow cytometry. Digital images were taken using a
Nikon Eclipse TS100 microscope, equipped with an Olympus
DP72 camera and Olympus DP controller software.
Estimation of Transduction Efficiency by Flow Cytometry
To estimate the percentage of YFP-expressing cells in cell
culture and chicken tissues, cells were analyzed using the LSRII
flow cytometer with FACSDiva software (BD Biosciences, Ness-
Ziona, Israel). Cultured cells (.1.2610
5) were trypsinized, washed
with PBS and immediately analyzed. For the liver tissue, pieces of
excised liver were minced with scissors and a single-cell suspension
was generated as described above and immediately analyzed.
Nucleic Acid Extraction
DNA was extracted from cells in culture or tissues using DNA
lysis buffer (10 mM Tris, 10 mM EDTA, 0.5% SDS, 200 mg/ml
proteinase K) at a ratio of 0.5 ml per well or per 0.05 g tissue, and
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respectively. RNA was eliminated by incubation of the DNA
samples with RNase at a final concentration of 25 mg/ml at 37uC
for 1 h, followed by extraction with phenol-chloroform and
ethanol precipitation.
Total RNA was extracted using RNAzol B solution (Tel-Test
Inc., Talron, Rehovot, Israel) according to the manufacturer’s
instructions. Briefly, 0.5 g of tissue, or subconfluent culture from a
six-well plate, was homogenized in 0.5 ml RNAzol B solution
using a Polytron PT3000 homogenizer (Kinematika, Labotal,
Jerusalem, Israel). After centrifugation, the RNA in the upper
phase was re-extracted with a phenol-chloroform solution and
precipitated with ethanol.
Turbo DNA-free kit was used for DNA elimination according to
the manufacturer’s protocol (Ambion, Agenteck, Tel-Aviv, Israel).
The concentration and integrity of the extracted RNA were
determined by spectrophotometry and gel electrophoresis, respec-
tively.
PCR and RT-PCR
PCR was carried out in a 20 ml final volume, using genomic
DNA (50 ng) or cDNA (see below), with primers for the transgenic
a-MSH (RT-PCR F: 59-TGGAAGATGCCGAGATCGTGC-39,
RT-PCR R: 59- TCCTTACCGCTTCTTGCCCAC -39)o r
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (F: 59-
GGAGCCAAAAGGGTCATCATC-39,R :5 9-AGGTCAGGTC-
CACCACTGACA-39), generating amplicons of 234 bp and
397 bp, respectively. The a-MSH forward primer is specific for
the junction between the viral and POMC sequences (Figure S1),
and this amplification is therefore specific for the recombinant a-
MSH. The cycling protocol was: 94uC denaturation for 3 min,
followed by five cycles of 94uC denaturation (30 s), 65uC
annealing (60 s) and 72uC extension (30 s), another five cycles as
above but with annealing temperature of 60uC, and an additional
25 cycles with annealing temperature of 55uC. RT reactions were
carried out using 2 mg total RNA as template and a high-capacity
cDNA reverse transcription kit (Applied Biosystems, Agentek,
Yavne, Israel) according to the manufacturer’s protocol.
Detection of FIV Integration into the Chicken Genome
using Repetitive DNA (CR1) PCR
Genomic DNA was prepared 14 days after in vitro transduction
of primary cell cultures from E11 embryo liver and muscle tissues,
with FIV-YFP at multiplicity of infection (MOI) of one. The initial
PCR was performed in a 20 ml reaction volume, using 100 ng
template genomic DNA with one of the following CR1 primers:
CR1-1 F: 59-TGGTTGGGTTGGAAGGGACC-39,R :5 9
GGTCCCTTCCAACCCAACCA-39; CR1-3 F: 59-
TCCATGGCCTTGGGCACATC-3, R: 59-GATGTGCC-
CAAGGCCATGGA-39, in combination with one of the long
terminal repeat (LTR)-specific primers encoded by FIV-YFP: right
LTR F: 59-GGAGTCTCTTTGTTGAGGAC-39, left LTR R: 59-
CGAAGTTCTCGGCCCGGATTCC-39. Control reactions con-
tained the same DNA templates and LTR-specific primers but
lacked the CR1 primers. Altogether, for each template DNA, eight
CR1-LTR reactions for the first PCR and two control LTR
reactions were performed. Additional controls consisted of DNA
template from non-transduced liver and muscle cells. The protocol
of amplification was as described above but elongation was
extended to 8 min at 68uC to allow for long range amplification,
using the BIO-X-ACT Long DNA Polymerase (Bioline, Origolab,
Jerusalem, Israel). A second, ‘‘nested’’ PCR was carried out with
1 ml of a 1:1000 dilution of the first PCR product as template and
nested primers for the left and right FIV-LTRs: left nested LTR F:
59-GGAGTCTCTTTGTTGAGGAC-39,R :5 9-ATTCCGA-
GACCTCACAGGTA-39 and right nested LTR F: 59-
CTCCCTTGAGGCTCCCACAG-39,R :5 9-
CGAAGTTCTCGGCCCGGATTC-39.
qPCR
qPCR was performed using Fast SYBR Green Master Mix
(Applied Biosystems) according to the manufacturer’s protocol.
The cDNA templates of the indicated tissues (2 ml) were used with
primers specific for the recombinant sequence of a-MSH (F: 59-
TTGCTGGCCTTGCTGCTT-39 and R: 59-GCACTCCAG-
CAGGTTGCTTT-39), resulting in a 101 bp fragment. The
forward primer was designed according to the adjacent virus-
derived sequence, placed upstream of the ATG signal. Therefore,
these primers were specific to the exogenous a-MSH sequence (the
position of the primers is illustrated in Figure S1). The YFP
primers used were F: 59-TCAGCTCGATGCGGTTCAC-39 and
R: 59-GTCCAGGAGCGCACCATCT-39, giving rise to a 99-bp
amplicon. Gene expression was normalized to a housekeeping
gene encoding chicken ribosomal 17 S protein (accession number
X07257). The specific primers F: 59- GACCCGGACACCAAG-
GAAAT-39 and R: 59- GCGGCGTTTTGAAGTTCATC-39 give
rise to a 100 bp product. Standard curve slope for these primers
was -3.331 and R
2 was 0.994. Another set of primers for the 17 S
ribosomal protein gene (F: 59-AAGCTGCAGGAGGAGGA-
GAGG-39 and R: 59- GGTTGGACAGGCTGCCGAAGT-39,
giving a 136-bp amplicon, gave similar results (not shown).
Normalization with GAPDH (F: 59-GCACCAC-
CAACTGCCTGG-39 and R: 59-CTGTGTGGCTGTGATGG-
CAT-39 giving a 100 bp amplicon) gave essentially similar results,
but expression of GAPDH was lower in the spleen than in the liver
(not shown). PCRs were performed using the StepOnePlus
TM
Real-Time PCR System (Applied Biosystems) with the following
cycling protocol: 95uC denaturation for 10 min, followed by 40
cycles of 95uC denaturation (15us), 60uC annealing (40us) and
72uC extension (30 s). At the end of the real-time PCR, a melting
curve was determined to verify the presence of a single amplicon.
Relative quantification was calculated using the 2
2DCt method. All
experiments were run in triplicates and repeated until variations
between repeats were below 10%. The PCR products were
purified and fragment identity was determined by sequencing.
Immunofluorescence
Tissue samples were fixed in 4% PFA in PBS overnight at 4uC.
For analysis of paraffin sections, tissues were embedded in paraffin
and sliced into 10-mm sections using a Leica RM2255 microtome.
Slides were treated with 3% H2O2 in PBS for 30 min at room
temperature, blocked with 10% goat serum in PBS for 1 h, and
incubated with rabbit anti-GFP (diluted 1:500, Invitrogen,
Rhenium, Israel) at 4uC overnight. Following washes in PBS-
0.05% Tween (PBS-T), slides were incubated with goat anti-rabbit
Alexa 488 antibody (diluted 1:500, Invitrogen) at room temper-
ature for 1 h, and washed with PBS-T. For labeling of smooth
muscle actin (SMA), slides were similarly incubated with mouse
anti-SMA antibody (diluted 1:200, DAKO, Enco, Petach-Tikvah,
Israel), followed by goat anti-mouse Alexa 594 antibody (diluted
1:500, Invitrogen). Finally, sections were stained with 49,6-
diamidino-2-phenylindole (DAPI) and digital images were taken
using a Nikon Eclipse e400 upright microscope, equipped with an
Olympus DP72 camera and Olympus DP Controller software.
Confocal images were obtained using an Olympus IX81 inverted
laser scanning microscope with Fluoview-500 software.
For whole-mount immunofluorescence analysis of excised tissue
pieces (sized 5–10 mm), double-labeling was performed according
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1:700, Invitrogen) and mouse anti-SMA (diluted 1:200) antibodies
were used, followed by goat anti-rabbit Alexa 488 or anti-mouse
Alexa 594 antibodies (both diluted 1:700). Clearing of the double-
labeled pieces of liver tissue with benzyl alcohol and benzyl
benzoate (Sigma-Aldrich) was performed as described previously
[24]. Images were taken using the Olympus SZX16 epi-fluorescent
stereomicroscope equipped with an Olympus DP72 camera.
Analysis of Cell Viability and Proliferation
Apoptosis of YFP-expressing cells was examined in paraffin
sections using the In Situ Cell Death Detection Kit, TMR red
(Roche Diagnostics; Dyn Diagnostics Ltd., Caesarea, Israel),
which stains nicked DNA by end labeling of terminal deoxynu-
cleotidyl transferase dUTP (TUNEL). Cell proliferation was
demonstrated by immunofluorescence using anti-proliferating cell
nuclear antigen (anti-PCNA, diluted 1:200, Dako) followed by
staining with goat anti-mouse Alexa 594 antibody (diluted 1:500).
Detection of a-MSH Peptide by Radioimmunoassay (RIA)
Production of a-MSH peptide by HEK293T cells was examined
10daysaftertransductionwithFIV-a-MSHvectors,usingaRIAkit
(EURIA- a-MSH; Euro Diagnostica AB, Malmo, Sweden) accord-
ingtothemanufacturer’sprotocol.HEK293Tcellstransducedwith
FIV-YFPvectorsservedasacontrol.Conditionedmediumof10 cm
culture dish, incubated for 24 h with 6 ml of Opti-MEM culture
medium (Gibco, Rhenium), was collected and cell extracts were
prepared using 300 ml of CHAPS lysis buffer (1% w/v CHAPS,
30 mM Tris pH 7.5, 150 mM NaCl, Complete protease inhibitor
cocktail from Roche Diagnostics, 50 mg/ml DNase and 10 mg/ml
RNase. After 10 min incubation on ice, cell debris was pelleted by
centrifugation at 10,000 g for 10 min. Supernatant was kept at
220uC until assay. Cell extracts and conditioned media were
analyzedin100 mlsamplesdiluted3-and10-fold(usingthesupplied
dilutionbuffer)andresultswerecalibratedwiththea-MSHtitration
curve supplied with the RIA kit.
Statistical Analysis
Statistical analyses were performed by one-way ANOVA and
Tukey-Kramer honestly significant difference test. Comparison of
hatching rates of the different experimental treatments was
performed using the chi-squared test.
Results
Transgene Expression in Transduced Cells of Embryonic
Primary Cultures
To test the efficacy of FIV particles for gene delivery into
somatic cells of chick embryos, primary cultures of liver, spleen,
kidney, brain, heart and muscle tissues were prepared from E11
chick embryos, and transduced with FIV-YFP (6.5610
4 TU/ml).
Expression of YFP was demonstrated 48 h later in all transduced
cell types (Figure 1). Quantification of the results by flow cytometry
(FACS) analysis revealed 1.3, 1.2, 2.8, 2.7, 2 and 4.7% YFP-
expressing cells in the liver, spleen, kidney, brain, muscle and heart
primary cultures, respectively (Figure S2). These results provide a
first demonstration of FIV particle transduction of various types of
primary cultured cells derived from chick embryos in vitro.
In vivo Transduction of Chicken Embryonic Tissues with
Lentiviral Particles
The procedure used for the introduction of foreign genes into
chicken tissues in ovo via administration of lentiviral particles is
presented in detail in Figure 2. Recombinant lentiviral particles,
harboring genes of interest, are injected into a selected CAM vein
through the eggshell membrane after removal of a small piece of
the calcified shell. The shell is re-sealed and embryos are
incubated to hatching. Hatchability rate was reduced by an
average of 9% in PBS or viral injected eggs, as compared to non-
treated eggs following this procedure (Figure 2D).
Transgene Expression in Tissues of Hatched Chicks
Following in ovo Transduction with FIV-YFP
Following in ovo transduction with FIV-YFP (Figure 2), various
tissues from post-hatch chicks were analyzed for reporter gene
expression by immunostaining using anti-GFP antibody (which
also recognizes YFP that differs from GFP only by a Y66W
substitution). As demonstrated in Figure 3, clusters of YFP-
expressing cells were detected by whole-mount immunostaining on
pieces of liver tissue excised on days 2 and 40 post-hatch (Figure 3B
& C, respectively) from FIV-YFP-treated chicks, but not from
control chicks treated with PBS (Figure 3A) or with FIV particles,
carrying another cDNA (a-MSH, data not shown). Similar clusters
of YFP-expressing cells were also detected by immunostaining of
paraffin sections of liver from 2-day-old chicks treated with FIV-
YFP (Figure 3D & E). Images show YFP staining in cells with
characteristic hepatocyte morphology (Figure 3D) as well as cells
associated with blood vessels (Figure 3E). Transduction of cells
associated with blood vessels in the liver was confirmed by double-
staining with anti-GFP and anti-SMA antibodies (Figure 3H). An
additional view of YFP-expressing cell clusters, which predomi-
nantly have characteristic hepatocyte morphology, is demonstrat-
ed in 3D images of liver tissue, stained with anti-GFP (Movie S1)
or double stained with anti-GFP and anti-SMA antibodies (Movie
S2). Another demonstration of the typical morphology of
hepatocytes is provided in Figure S3. These images show that
both GFP-positive and negative cells seem similar, as well as
hepatic tissue from control non-transduced chicks.
YFP-expressing cells were also observed in spleen sections of
FIV-treated chicks (Figure 3F & G). A higher frequency of YFP-
expressing cells was observed, but in small clusters of two or three
cells each. Examination of paraffin sections from kidney, brain,
heart and muscle tissues revealed sporadic YFP expressing cells
(data not shown). Yet, the appearance of YFP expression in these
tissues was significantly lower compared to liver and spleen.
To estimate the number of cells in a representative YFP positive
cluster, several serial sections of paraffin-embedded liver sections
were analyzed (Figure 4). The signals were observed at the same
position in several serial sections indicating the specificity of the
detecting antibody and the three-dimensional structure of the
cluster. Given the estimation of 12- mm diameter for a chicken
liver cell [25], it can be assumed that most of the nuclei in each of
the consecutive 10 mm tissue slices (Figure 4E, arrowheads)
represent different cells in the cluster. For a rough estimation of
the number of cells in a cluster, the numbers of transduced cells’
nuclei per section in Figure 4A–E were 9, 10, 11, 12, & 8,
respectively, resulting in 50 nuclei of YFP-expressing cells.
To estimate the proportion of transduced cells in the liver, liver
cells were prepared from excised tissue samples and analyzed by
flow cytometry. As shown in Figure 5, the average percentage of
transduced cells was 0.4660.19 (n=3), a proportion similar to that
reported in mice following lentiviral transduction via tail injection
[26].
Further examinations of liver sections were performed to verify
the viability of the transduced cells (Figure 6). The possibility of
cell death through apoptosis was examined using TUNEL assay.
As demonstrated in Figure 6A & B, only very few TUNEL-positive
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chicks or controls, respectively. None of these appeared to co-
localize with YFP-expressing cells. The images in Figure 6
represent one example of 10 slides that were analyzed.
Immunostaining using anti-PCNA antibody, which is directed
against the auxiliary protein of DNA polymerase delta, was
performed to indicate cell proliferation. As shown in a represen-
tative image in Figure 6C, some PCNA signals were found to co-
localize with YFP fluorescence.
The PCNA and TUNEL analyses confirmed viability of the
YFP-transduced cells in the hatching chicks. These results are
compatible with the detection of YFP signals in pieces of liver
excised from 40-day-old chickens (51 days post transduction),
analyzed by whole-mount immunostaining (Figure 3C).
Taken together, these data demonstrate that in ovo injection of
lentiviral particles leads to stable transduction of somatic tissues
that can be detected post-hatch, primarily in the liver and spleen.
Transgene Expression Following Transduction with FIV-a-
MSH in vitro and in ovo
Once we had successfully observed YFP expression using the
CAM-injection approach, we set out to validate our findings by
analyzing the expression ofa functional gene, encoding the secreted
a-MSH peptide. This peptide has pleiotropic effects on energy
homeostasis, demonstrated mainly in mammalian species [27]. The
presenceofa-MSHwasfirstanalyzedattheDNAandmRNAlevels
following transduction of HEK293T cells in culture, with a FIV
vector carrying a-MSH (FIV-a-MSH). The a-MSH sequence was
detectedingenomicDNAsamplesextractedfromcellsharvested24
and 72 h after transduction, using primers specific for the
recombinant a-MSH (Figure 7A). A further indication of the
specificity of the PCR results was obtained by purification and
sequencing of the PCR product (not shown). Expression of a-MSH
mRNA in the transduced cells was next examined by RT-PCR.
Transcripts of the a-MSH-encoding sequence were detected in
transduced HEK293T cell cultures 20 days post-transduction
Figure 1. YFP expression following transduction of primary cultures of chick embryonic cells with FIV-YFP vectors. Primary cell
cultures from E11 chick embryos were transduced with FIV-YFP (2610
4 TU/well, in a 24-well plate) and YFP-expressing cells (green) were detected by
fluorescence microscopy, 48 h after transduction (A–F). The corresponding bright-field micrographs of the same cultures (A9–F9) demonstrate the
tissue-specific morphology of the cells. Scale bar=20 mm. Rate of transduction in each culture, determined by FACS analysis, is shown in Figure S2.
doi:10.1371/journal.pone.0036531.g001
Figure 2. Schematic representation of the gene-transfer procedure used to introduce foreign genes into chicken tissues. The gene-
delivery procedure: A. A gene of interest (such as YFP or a-MSH) is subcloned into the FIV-derived plasmid, pLionII, and the recombinant pLionII
plasmids are used as a part of a three-plasmid system to produce the corresponding viral particles (such as FIV-YFP or FIV-a-MSH). B. E11 embryos are
illuminated in a dark room and a prominent blood vessel of the CAM, approximately 1 cm below the air sac, is marked with a pencil. An oval window
of approximately 563 mm is carefully drilled into the eggshell around the marked blood vessel, using a Dremel 300JD multitool with aluminum-oxide
grinding stone (Dremel, Polack Supply, Haifa, Israel), and the drilled shell piece is gently removed using a fine forceps. Special care is taken to avoid
damaging the underlying eggshell membrane. The egg is then stabilized vertically and recombinant lentiviral particles (2610
6 TU in 100 ml PBS) are
injected through the transparent eggshell membrane into the blood vessel, using a 30 G needle. C. After hot-glue sealing of the eggshell window
[54], eggs are returned to the incubator until hatch. Scattered clusters of YFP-expressing cells in the liver are illustrated in green. D. The table
indicates the hatching rates determined for control non-injected chicks and chicks injected with PBS or viral particles. The hatching rate of injected
embryos was 81.8%, which by comparing to the un-injected control with 90% hatching rate, calculated to represent a 9% reduction in hatch. WPRE,
woodchuck hepatitis post-transcriptional regulatory element; pCMV, cytomegalovirus promoter.
doi:10.1371/journal.pone.0036531.g002
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reaction lacking template cDNA, and cDNA from non-transduced
cells.GAPDH-specificprimerswereusedasanadditionalcontrolto
demonstrate the integrity of the mRNA samples of the transduced
and nontransduced cells (Figure 7C).
Next,productionandsecretionofabioactivea-MSHpeptidewas
assessedbyRIA(Figure7D).Cellextractsandconditionedmediaof
HEK293T cells, transduced with FIV-a-MSH, produced RIA-
detectable peptide (852 and 1012 ng/ml, respectively). In contrast,
no RIA signal could be obtained in control cells transduced with
FIV-YFP (Figure 7D). These results indicate our ability to produce
active FIV-a-MSH particles, which are capable of directing the
production and secretion of a-MSH in transduced cells.
Following the confirmation of a-MSH expression, production
and secretion in cell culture, chick embryos were treated with the
same viral particles in ovo. Samples from liver, spleen, kidney,
brain, heart and muscle were excised two days post hatch and
subjected to qPCR using primers that specifically recognize the
recombinant a-MSH transcripts and not those of the endogenous
POMC (Figure S1). The transgene mRNA was detected in the
FIV-a-MSH treated chicks (Figure 8). The level of expression was
highest in the spleen and liver (48.4617.6 and 19.363.3,
respectively, in arbitrary units). Lower expression was observed
in the kidney (2.360.9) and brain (1.360.2), while no expression
could be detected in the heart or muscle. No expression of
recombinant a-MSH was detected in tissues collected from control
chicks treated with FIV-YFP virus (Figure 8). Moreover, liver
samples that were taken from 40 days old chickens (51 days after
injection) also demonstrated a-MSH expression, indicating the
stability of the transduction. Similar results were obtained also
with tissues excised at day 2-post hatch from FIV-YFP treated
chicks using YFP-specific primers (Figure 8, insert) with higher
relative expression in the liver and spleen.
Demonstration of Transgene Integration into the Chicken
Genome Using CR1-PCR
Primers matching the consensus sequences of the repetitive
DNA elements were originally used by Coullin et al. [28], for
primed in-situ labeling analysis. We employed the same primer
sequences to detect transgene integration into the chick genome
(Figure 9). For preparation of genomic DNA samples, liver and
muscle cell cultures of E11 chick embryos were transduced with
FIV-YFP, and 14 days later cells were harvested for DNA
isolation. As schematically demonstrated in Figure 9A, the
amplification of virus-derived LTR sequences in the second step
of the PCR critically depended on amplification by the CR1 and
LTR primers in the first step. As demonstrated in Figure 9B, PCR
product of the expected size was obtained using the nested primers
only in genomic DNA samples of the FIV-YFP transduced liver
and muscle cell cultures, and not in the non-transduced cell culture
controls. Therefore, this analysis demonstrates that transduction of
chicken cells results in integration of the FIV-associated transgene
into the host cell genome.
Altogether, these data demonstrate the feasibility of our simple
and original manipulation in chick embryos for the introduction of
foreign genes into chicken somatic tissues, primarily liver and
spleen.
Discussion
We present a novel approach for the introduction of foreign
genes into somatic tissues of chickens, by injection of FIV-derived
lentiviral particles into the CAM vasculature of embryos. Recent
progress has been reported in the successful production of
transgenic chicken lines [3–6,9,29]. However, these approaches
are highly complicated and costly [1,3], preventing their routine
laboratory use for studies of gene function. The advantages of the
technique described herein stems from its simplicity and high rates
of transgene transfer and chick hatchability. The well-documented
advantages of lentiviral vectors, particularly their ability to
integrate into the host-cell genome and their resistance to
downregulation by the endogenous immune system or other
cellular mechanisms [30,31], strongly support the potential of this
approach for gene transfer in chickens. This technique provides
the first affordable tool for constitutive production of secreted
proteins and peptides from the liver, for the study of their long-
term effects. This technique is expected to advance molecular-level
avian endocrinology research and enable identification of target
Figure 3. Immunofluorescence analyses of YFP expression in the liver and spleen of post-hatch chicks following in ovo FIV
administration. Whole-mount immunostaining with anti-GFP antibody (green) and anti-SMA antibody (red) was performed on pieces of livers from:
2-day-old chicks treated with either PBS (A) or FIV-YFP (B), and from 40-day-old FIV-YFP-treated chicks (C). Images were obtained using epi-
fluorescent stereomicroscope. Scale bar=200 mm for A and C, and 0.5 mm for B. Immunostaining of paraffin sections with anti-GFP antibody was
performed on liver (D&E ) and spleen (F&G ) tissues from 2-day-old chicks treated with FIV-YFP. For each of these sections, DAPI staining (blue) is
shown in the corresponding images (D9–G9) to indicate cell nuclei. Arrowheads mark nuclei of YFP-expressing cells with splenocyte morphology (F9).
Merged YFP and DAPI staining is shown in the corresponding D99–G99. Images were obtained by confocal microscopy except for E, E9 and E99, which
were obtained by epi-fluorescenct microscope. The arrow in E99 indicates a YFP-expressing cell with endothelial morphology located next to
transduced cells with hepatocyte morphology. H. Confocal images of whole-mount immunostained liver sample, using both anti-GFP (H) and anti-
SMA (H9) antibodies, confirmed the association of some of the YFP-expressing cells with blood vessels, which appear in yellow in the merged image
(H99). Scale bar=20 mm (D-G) and 50 mm (H).
doi:10.1371/journal.pone.0036531.g003
Figure 4. Serial paraffin sections of YFP-positive cell cluster in the liver. A cluster of YFP-expressing cells (green) was identified in five
consecutive liver sections (A–E) by immunofluorescence with anti-GFP antibody, demonstrating its 3D structure. DAPI staining (blue) indicates cells
nuclei. Arrowheads in E indicate nuclei of transduced cells. Scale bar=20 mm.
doi:10.1371/journal.pone.0036531.g004
Gene Transfer to Chicks via Lentiviral Vectors
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36531proteins with importance to agriculture-oriented research, devel-
opmental biology and evolution, among other fields. For evolution
studies in particular, the chicken provides an important perspec-
tive due to its evolutionary position between reptiles and other
vertebrates.
Although several types of lentiviruses, similarly pseudotyped
with VSV-G, have been previously used in chick embryos [4], the
use of FIV-based vectors for the delivery of foreign genes into
chicken tissues is demonstrated here for the first time. Therefore,
we first characterized the susceptibility of several chick embryonic
tissues in culture to FIV transduction. Cells derived from
embryonic liver, spleen, kidney, heart, brain and breast muscle
tissues were transduced with a low dose of FIV-YFP, and the
analysis indicated for the first time the susceptibility of the various
chick cell types examined to transduction by FIV-derived particles.
Injection of the lentiviral vectors into E11 chick embryos through
the CAM vasculature resulted in a more restricted tissue-specific
expression profile, with significantly higher relative levels of YFP
and a-MSH expression in the liver and spleen, as detected by
immunostaining for YFP, and qPCR for both YFP and a-MSH.
This transgene-expression profile is in accordance with findings in
rodents following lentiviral administration by tail vein injection to
adult and neonatal mice [26,32,33]. Given the similar tropism for
FIV transduction of these cell types in vitro, it seems logical to
assume that the observed profile of tissue transduction following
lentivirus application in vivo does not reflect viral tropism, but
probably structural differences in the organization of the
vasculature of the relevant tissues in the animal. Such a structural
explanation could be provided by the fenestrated capillaries
characteristic of the spleen, liver and myeloid bone marrow [34],
which seem wide enough to facilitate penetration of the lentiviral
particles (approximately 100 nm in diameter) [35] from the
circulation to the cells of these tissues.
Relatively high efficiency of lentiviral transduction in the liver
was demonstrated in a variety of ways: (i) whole-mount
immunostaining of pieces of liver tissue from 2- and 40-day-old
chickens, (ii) immunostaning of paraffin sections, (iii) 3D confocal
imaging, (iv) flow cytometry, and (v) qPCR. This relatively high
efficiency of transduction is important, since the liver is among the
largest tissues in the body and is highly specialized in processing
secreted proteins. Therefore, manipulation of the chicken’s liver by
introducing genes encoding secreted proteins will provide a highly
useful tool for endocrinological and other studies. Moreover, the
pattern of transduction of the liver tissue, characterized by cell
Figure 5. Estimation of transduction efficiency in livers of in ovo FIV-YFP transduced chicks by flow cytometry. Liver samples from 2-
day-old control chicks treated with PBS (A) or FIV-YFP (B) were analyzed by flow cytometry. One representative image from the control PBS and FIV-
YFP treated chick groups is shown. Cells in each sample were selected (window P1 in A) and YFP fluorescence was analyzed (B). While no obvious
signals were obtained in the control samples, the rate of transduced liver cells in the samples from FIV-YFP treated chicks was 0.4660.19% (n=3).
Blue and red mark the YFP-positive and negative cells, respectively. The sample with the highest transduction rate (0.8%) is presented.
doi:10.1371/journal.pone.0036531.g005
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(A) and controls (B), immunostained with anti-GFP antibody (green) and DAPI (blue), were analyzed for apoptosis using TUNEL assay (A9,B 9, red). Very
low incidence of cell death was observed in both groups of chicks. The areas of the TUNEL positive cells were enlarged in the white boxes (inserts).
Scale=100 mm. Liver paraffin sections were immunostained with anti-GFP and DAPI (C, green and blue, respectively) and anti-PCNA (C9, red). Co-
labeling of a group of hepatocytes is demonstrated (C99), indicating actively proliferating FIV-transduced cells. Scale=50 mm.
doi:10.1371/journal.pone.0036531.g006
Figure 7. FIV-a-MSH transduction of HEK293T cells: characterization at the DNA, mRNA and protein levels. A. Genomic DNA extracted
either before (293T) or 24 and 72 h after transduction of HEK293T cells with FIV-a-MSH (293T-a-MSH) was analyzed by PCR using the recombinant a-
MSH-specific primers. The plasmid pLionII- a -MSH was used to demonstrate the expected size fragment. B. RNA samples, prepared from similarly
treated cell cultures 20 days after transduction, were analyzed by RT-PCR using the same primers. C. The integrity of the mRNA in the control and
transduced culture cells was demonstrated using the GAPDH primers. D. Production and secretion of a-MSH peptide was demonstrated by RIA. a-
MSH peptide was detected in cell lysate (L) and culture medium (CM) of HEK293T cells, 10 days after transduction with FIV-a-MSH. No signal was
detected in cell lysate or culture medium of control HEK293T cells, transduced with FIV-YFP (293T-YFP).
doi:10.1371/journal.pone.0036531.g007
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process of liver regeneration, as a potential model for therapeu-
tically oriented studies of liver diseases [36].
The immunofluorescence analyses, with whole-mount speci-
mens and paraffin sections, indicated transduction of cells with
characteristic hepatic morphology as well as with characteristics of
other cell types associated with blood vessels. The presence of YFP
in cells associated with blood vessels, in addition to hepatocytes,
was expected, since viruses were injected into the chick circulation.
While clusters of transduced cells in the liver of 2-day-old chicks
were estimated to consist of about 50 cells, clusters in the spleen
were much smaller, with only a few cells each. This difference is
compatible with the different cell-multiplication rates in these
tissues during the period of chick development between E11 and
day 2-after hatch [37], and support the hypothesis that the
appearance of transduced cells in clusters means that each infected
cell transmits the transgene to its daughter cells. The smaller
clusters of transduced cells in the spleen were seen at a higher
density in each slide (not shown), compatible with the similar
overall range of expression level obtained in the qPCR of the
spleen and liver with the YFP and a-MSH specific primers.
Furthermore, flow cytometry analysis demonstrated 0.4660.19%
infected cells in the liver, similar to the frequencies reported
following injection of lentiviruses into mice tails [26].
The pACTH1-17 expression cassette used in the present study
to generate the pLionII- a-MSH construct and the FIV-a-MSH
lentiviral particles has been used previously to direct the
production and secretion of a bioactive a-MSH peptide in rodents
[23,38,39]. The production of a bioactive peptide was demon-
strated in those reports through a-MSH protective effect against
liver fibrosis [39], ocular autoimmune diseases [38], as well as
experimental encephalomyelitis [23]. Here we demonstrate that
FIV-a-MSH particles can transduce HEK293T cells, leading to
the detection of exogenous a-MSH sequences by PCR, RT-PCR,
and qPCR. In addition, we provide the first RIA identification of
an active a-MSH product of the FIV-a-MSH. RIA detection of a-
MSH peptides in both cell lysate and conditioned medium of
HEK293T cells, transduced with FIV-a-MSH, demonstrate that
a-MSH production and secretion can be directed through FIV
transduction. In mammals, a-MSH has been shown to participate
in the control of energy homeostasis, as it is a primary target of the
satiety hormone leptin [27], and to be involved in pigmentation
and regulation of the immune response [40,41]. In chickens, data
on the physiological roles of a-MSH were obtained in our and
others’ laboratories, mainly by characterization of short-term
physiological effects following a single administration of a-MSH or
its synthetic analogs to young chicks [42–48]. Therefore, we
strongly believe that the technique presented here will dramati-
cally advance the study of a-MSH in chickens, as a proof of
concept, by providing an assay system for long-term studies in vivo.
Integration of FIV-derived cDNA into the host cell genome was
demonstrated using a CR1-PCR approach, which makes use of
repetitive genomic sequences to amplify the ends of the viral LTR
sequences. This approach is based on the Alu-PCR protocols used
in our previous study to demonstrate genomic integration of FIV-
derived sequences in mammals [16], and is applied here to the
chicken genome for the first time, by making use of previously
characterized CR1 consensus sequences [28]. The CR1 repeats
are the most abundant repeat family in avian species, belonging to
long interspersed nuclear elements with more than 200,000 copies,
accounting for about 80% of the chicken interspersed repeats [49].
They are significantly less abundant than the Alu sequences in the
human genome, estimated to be about a million per haploid
genome [50]. The fact that this approach gave the expected results
despite this differential abundance might support the speculation
that the spread of CR1 sequences, and possibly also the integration
of viral vectors, has some bias in favor of sites of transcriptionally
active chromatin. Notably, demonstration of transgene integration
into the chick genome supports the stability and robustness of our
in ovo transduction approach, and is in accordance with our
Figure 8. a-MSH expression in tissues of FIV-a-MSH-treated chicks. qPCR analysis of the indicated tissues from 2-day post-hatch chicks was
performed following in-ovo treatment with FIV-a-MSH particles (2610
6 TU/chick), as described in Figure 2. Results of transgene expression in tissues
of each chick are indicated by a different color (n=6). Spleen and liver tissues of chicks treated with FIV-YFP particles served as negative controls.
Expression of a-MSH in the liver is also demonstrated in 40-day-old chickens (n=4). A similar analysis performed using tissues of 2-day-old chicks
treated with FIV-YFP, but with YFP-specific primers, is shown in the insert (n=4). A higher level of transgene expression in the liver and spleen was
common to both transgenes. The results are presented as mean 6 SEM of triplicate runs (error bars are contained within the symbols).
doi:10.1371/journal.pone.0036531.g008
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chickens.
Future use of lentiviral particles to deliver transgenes using our
approach might entail using liver-specific promoters, such as the
human a-antitrypsin (hAAT) [51], to restrict transgene expression
to the liver. The advantages of using these promoters are twofold:
first, it reduces possible undesired effects due to expression in other
tissues, and second, their nonviral origin reduces the chances of
downregulation of the transgene [32], which was reflected to some
extent in the current study by the lower qPCR signals obtained for
the livers of 40-day-old vs. 2-day-old chickens. We have previously
demonstrated prolonged and stable hAAT-driven gene expression
in liver cell lines and murine livers using FIV vectors [16,33]. In
addition, we have reported efficient hAAT-driven gene expression
in chicken liver using a naked DNA-delivery system [52]: by using
the hydrodynamics-based gene-transfer method to direct gene
expression in chick liver, we detected physiologically significant
levels of transgene (human coagulation factor IX) in the circulation
using the hAAT promoter [52]. This naked DNA-transfer
technique does not involve DNA integration into the host-cell
genome, and the introduced plasmid persisted in its original
episomal form [53]. Nevertheless, that report indicated that the
hAAT promoter can be used to drive expression of foreign genes
in chickens.
In summary, we have established a new approach for the
transfer of genes to chickens. The use of lentiviral vectors enables
integration of transgenes into the host-cell genome, while injection
into the CAM vasculature provides unique accessibility to the
chick embryo. The technique is best suited for the study of
endocrinology in avian species, by directing genes encoding
secreted hormones and peptides to the liver tissue. This procedure
should also be useful for experiments in developmental biology,
enabling the monitoring of small subpopulations of transgenic cells
within a tissue. In addition, it should be possible to co-transduce a
gene of interest and a reporter gene and study the effects of this
manipulation in a background of non-transduced cells, on either
cell morphology as seen under a microscope, or on gene
expression as detected by double-immunostaining. Given the
Figure 9. CR1-PCR analysis for genomic integration of YFP in chicken cells, transduced with FIV-YFP vectors. Schematic representation
of the two-step PCR approach using the CR1- and LTR-specific primers. Diluted (1:1000) mixes from the first long PCRs, employing CR1 and LTR
primers, were used as templates for short nested PCRs with nested LTR primers. In the absence of genomic integration, no signals are expected in the
nested PCR. This is indicated by the control long PCR with no CR1 primers. B. Nested PCR products separated on 2% agarose gel, obtained using as
templates the first long-PCR DNAs, which were prepared 14 days after in vitro transduction with FIV-YFP, from E11 liver and muscle cells. The primers
used for the first long PCR are indicated: the LTR primers were 59LTR (59L) and 39LTR (39L); the CR1 primers were CR1-1F (C1F), CR1-1R (C1R), CR1-3F
(C3F) and CR1-3R (C3R). The nested primers are indicated in Materials and Methods. Neither the controls without CR1 primers, nor the control using
DNA from non-transduced cell cultures gave a signal. The expected size fragments were 120 bp for the 59LTR and 110 bp for the 39LTR. The products
were confirmed by sequencing. These results indicate genomic integration of FIV-YFP-derived cDNA in the host chicken cells. M, molecular weight
markers.
doi:10.1371/journal.pone.0036531.g009
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introduce genes coding for secreted proteins into the liver is
expected to be highly useful and provide new opportunities for
agricultural and academic research in these animals. Being highly
specialized in processing secreted proteins and among the largest
organs of the body, the liver is an optimal target for producing and
secreting exogenous proteins of interest for the study of gene
function in chickens.
Supporting Information
Figure S1 Position of primers used for a-MSH amplifi-
cation. The positions of the qPCR and RT-PCR primers are
shown, relative to the sequence of the recombinant a-MSH gene.
Note that for both primer sets, the forward primers match the
pLionII backbone sequence, thus rendering specificity of the PCR
amplification for recombinant a-MSH only.
(TIF)
Figure S2 Flow cytometry of primary cultures from E11
chick embryos following in vitro transduction with FIV-
YFP particles. The indicated primary cultures of E11 chick
embryos were transduced with FIV-YFP at a MOI of 0.1, as
described in the Materials and Methods and Figure 1. The rate of
transduction was analyzed by flow cytometry in comparison to
control non-transduced cells. YFP-positive cells are indicated in
blue. The rest of the cells are indicated in red.
(TIF)
Figure S3 Immunofluorescence analysis of YFP expres-
sion in the liver of post-hatch chicks, following in ovo
administration of vehicle or viral particles encoding
YFP. Paraffin sections of chicks liver tissues were subjected to
immunofluorescence, using anti-GFP antibody (green). Similar
tissue and cell morphology was observed in both YFP-expressing
cells and non-transduced cells (A), as well as in liver cells of vehicle
treated chicks (B). Scale bar=100 mm
(TIF)
Movie S1 3D confocal illustration of YFP-positive
hepatocyets: whole-mount staining with anti-GFP anti-
body. Nuclei were stained with DAPI.
(AVI)
Movie S2 3D confocal illustration of YFP-positive cells
in the liver, demonstrating their association with blood
vessels: whole-mount staining with anti-GFP and anti-
SMA antibodies. Nuclei were stained with DAPI.
(AVI)
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